FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381376570> ?p ?o ?g. }

• W4381376570 abstract "Introduction: Long term insulin requirements following TPIAT range from insulin independence to full (high) dose daily insulin (&gt;0.5 units/kg/day). Markers of islet cell autoimmunity are used in children to predict type 1 diabetes risk. However, no studies have explored whether an association exists between islet cell autoimmunity and insulin requirement following TPIAT in children. We hypothesized that children with islet cell autoantibody formation were more likely to have a persistent insulin requirement following TPIAT. Methods: All children who underwent TPIAT between 2015 and 2021 at our institution were eligible for inclusion. Islet cell autoimmunity was defined as positive islet cell autoantibody screen for one or more of the following types of autoantibodies: Glutamic Acid Decarboxylase (GAD), Islet Antigen-2 (IA-2), Insulin (IAA), or Zinc Transporter 8 (ZnT8). Patients were screened prior to TPIAT and every six months following TPIAT for up to three years. In all, 73 patients were included in the analysis. Total daily insulin dose was determined for each patient at each time interval. Chi-square or Fisher’s exact tests were used to compare proportions. Results: Of patients with 12-month data (n=38), 47% of islet cell autoantibody negative patients were off insulin vs 26% of antibody positive patients (p=0.19). This trend was significant at 18, 24, and 36 months after TPIAT. At 18 months, 90% (9/10) of antibody negative patients were off insulin vs 29% (4/14) of antibody positive patients (p=0.005). At 24 months, 73% (8/11) of antibody negative patients were off insulin vs 23% (3/13) of antibody positive patients (p=0.04). At 36 months, 100% (8/8) of antibody negative patients were off insulin compared to 0% (0/9) of antibody positive patients (p&lt;0.0001). Conclusions: The presence of pancreatic islet cell antibodies was associated with persistent insulin requirement after TPIAT. Disclosure A.R.Lavik: None. C.M.O.Lowe: None. S.E.Tellez: None. L.Hornung: None. C.Heinzman: None. J.D.Nathan: None. M.Abu-el-haija: None. D.A.Elder: None." @default.
• W4381376570 created "2023-06-21" @default.
• W4381376570 creator A5008055771 @default.
• W4381376570 creator A5024505737 @default.
• W4381376570 creator A5038783956 @default.
• W4381376570 creator A5045290256 @default.
• W4381376570 creator A5050157265 @default.
• W4381376570 creator A5052726389 @default.
• W4381376570 creator A5056109999 @default.
• W4381376570 creator A5086221072 @default.
• W4381376570 date "2023-06-20" @default.
• W4381376570 modified "2023-09-26" @default.
• W4381376570 title "1481-P: Islet Cell Autoantibody Formation and Its Effect on Insulin Requirement after Total Pancreatectomy with Islet Autotransplantation (TPIAT)" @default.
• W4381376570 doi "https://doi.org/10.2337/db23-1481-p" @default.
• W4381376570 hasPublicationYear "2023" @default.
• W4381376570 type Work @default.
• W4381376570 citedByCount "0" @default.
• W4381376570 crossrefType "journal-article" @default.
• W4381376570 hasAuthorship W4381376570A5008055771 @default.
• W4381376570 hasAuthorship W4381376570A5024505737 @default.
• W4381376570 hasAuthorship W4381376570A5038783956 @default.
• W4381376570 hasAuthorship W4381376570A5045290256 @default.
• W4381376570 hasAuthorship W4381376570A5050157265 @default.
• W4381376570 hasAuthorship W4381376570A5052726389 @default.
• W4381376570 hasAuthorship W4381376570A5056109999 @default.
• W4381376570 hasAuthorship W4381376570A5086221072 @default.
• W4381376570 hasConcept C126322002 @default.
• W4381376570 hasConcept C134018914 @default.
• W4381376570 hasConcept C159654299 @default.
• W4381376570 hasConcept C163764329 @default.
• W4381376570 hasConcept C165220095 @default.
• W4381376570 hasConcept C203014093 @default.
• W4381376570 hasConcept C2779306644 @default.
• W4381376570 hasConcept C2780130043 @default.
• W4381376570 hasConcept C2781232474 @default.
• W4381376570 hasConcept C555293320 @default.
• W4381376570 hasConcept C71924100 @default.
• W4381376570 hasConceptScore W4381376570C126322002 @default.
• W4381376570 hasConceptScore W4381376570C134018914 @default.
• W4381376570 hasConceptScore W4381376570C159654299 @default.
• W4381376570 hasConceptScore W4381376570C163764329 @default.
• W4381376570 hasConceptScore W4381376570C165220095 @default.
• W4381376570 hasConceptScore W4381376570C203014093 @default.
• W4381376570 hasConceptScore W4381376570C2779306644 @default.
• W4381376570 hasConceptScore W4381376570C2780130043 @default.
• W4381376570 hasConceptScore W4381376570C2781232474 @default.
• W4381376570 hasConceptScore W4381376570C555293320 @default.
• W4381376570 hasConceptScore W4381376570C71924100 @default.
• W4381376570 hasIssue "Supplement_1" @default.
• W4381376570 hasLocation W43813765701 @default.
• W4381376570 hasOpenAccess W4381376570 @default.
• W4381376570 hasPrimaryLocation W43813765701 @default.
• W4381376570 hasRelatedWork W1973049774 @default.
• W4381376570 hasRelatedWork W1985965417 @default.
• W4381376570 hasRelatedWork W1986775667 @default.
• W4381376570 hasRelatedWork W2030768859 @default.
• W4381376570 hasRelatedWork W2031301348 @default.
• W4381376570 hasRelatedWork W2064538767 @default.
• W4381376570 hasRelatedWork W2069537429 @default.
• W4381376570 hasRelatedWork W2069827981 @default.
• W4381376570 hasRelatedWork W2079112323 @default.
• W4381376570 hasRelatedWork W4384455672 @default.
• W4381376570 hasVolume "72" @default.
• W4381376570 isParatext "false" @default.
• W4381376570 isRetracted "false" @default.
• W4381376570 workType "article" @default.